These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5109250)

  • 21. Effects of a central stimulant substance isolated from the sea anemone Stoichactis kenti on brain monoamines of the mouse.
    Turlapaty P; Shibata S; Norton TR; Kuchii M
    Eur J Pharmacol; 1973 Dec; 24(3):359-65. PubMed ID: 4148845
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of alpha- and beta-adrenoblocking agents on some central effect of phenamine].
    Gura CIa; Raevskiĭ KS
    Farmakol Toksikol; 1970; 33(3):267-71. PubMed ID: 4393829
    [No Abstract]   [Full Text] [Related]  

  • 23. Altered sensitivity to footshock and decreased brain content of serotonin following brain lesions in the rat.
    Lints CE; Harvey JA
    J Comp Physiol Psychol; 1969 Jan; 67(1):23-31. PubMed ID: 5787808
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of 6-hydroxydopamine treatments on active avoidance responding: evidence for involvement of brain dopamine.
    Cooper BR; Breese GR; Grant LD; Howard JL
    J Pharmacol Exp Ther; 1973 May; 185(2):358-70. PubMed ID: 4703827
    [No Abstract]   [Full Text] [Related]  

  • 25. Narcotic withdrawal like mouse jumping produced by amphetamine and L-DOPA.
    Lal H; Colpaert FC; Laduron P
    Eur J Pharmacol; 1975 Jan; 30(1):113-6. PubMed ID: 1168136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of intraventricular infusion of dopamine and norepinephrine on motor activity.
    Geyer MA; Segal DS; Mandell AJ
    Physiol Behav; 1972 Apr; 8(4):653-8. PubMed ID: 5038135
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of the effects of D-amphetamine and L-amphetamine in reversing depression of mouse locomotor activity caused by reserpine.
    Proctor CD; Kirby J; Wood MH; Wade LH; King PK
    Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):108-15. PubMed ID: 4451411
    [No Abstract]   [Full Text] [Related]  

  • 28. Activity level and accumulation of tritiated norepinephrine in rat brain.
    Stone EA; DiCara LV
    Life Sci; 1969 Apr; 8(7):433-9. PubMed ID: 5769452
    [No Abstract]   [Full Text] [Related]  

  • 29. Analysis of the effects on body temperature of intracerebroventricular injection in anaesthetized dogs of gamma-aminobutyric acid.
    Dhumal VR; Gulati OD; Raghunath PR; Sivaramakrishna N
    Br J Pharmacol; 1974 Apr; 50(4):513-24. PubMed ID: 4155652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antagonism of psychostimulant 2-phenyl-5,5-dimethyl-tetrahydro-1,4-oxazine hydrochloride (G 130) to central nervous system depressing drugs. Monoamine oxidase inhibitory activity and norepinephrine and serotonin induced changes. Comparison with dL-amphetamine.
    Fanelli O; Mazzoncini V; Trallori L
    Arzneimittelforschung; 1974 Dec; 24(12):2025-9. PubMed ID: 4480283
    [No Abstract]   [Full Text] [Related]  

  • 31. Role of catecholamines in the central effects of amphetamine.
    Pfeifer AK; György L; Fodor M
    Acta Med Acad Sci Hung; 1968; 25(3):441-50. PubMed ID: 5720870
    [No Abstract]   [Full Text] [Related]  

  • 32. Behavioural effects of yohimbine administered intraventricularly in the rat.
    Zebrowska-Lupina I; Kleinrok Z
    Psychopharmacologia; 1973; 33(3):267-75. PubMed ID: 4785908
    [No Abstract]   [Full Text] [Related]  

  • 33. A study of hypertension: participation of central adrenaergic mechanism on the angiotensin II-induced hypertension.
    Iijima M; Yamamoto N; Kitamura Y; Yasugi T; Hatano M
    Jpn Circ J; 1977 Mar; 41(3):267-79. PubMed ID: 859212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of 4-chlorophenoxyamphetamine (A-6587), d-amphetamine and 4-chloroamphetamine on brain biogenic amines and behavior in mice.
    Everett GM; Yellin TO
    Res Commun Chem Pathol Pharmacol; 1971; 2(4):407-13. PubMed ID: 4400361
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of 6-hydroxydopamine on CNS catecholamines, spontaneous motor activity and amphetamine induced hyperactivity in rats.
    Evetts KD; Uretsky NJ; Iversen LL; Iversen SD
    Nature; 1970 Mar; 225(5236):961-2. PubMed ID: 5415137
    [No Abstract]   [Full Text] [Related]  

  • 36. 3-methoxy-4-hydroxyphenylglycol excretion and behavioural changes in rat and monkey after central sympathecomy with 6-hydroxydopamine.
    Breese GR; Prange AJ; Howard JL; Lipton MA; McKinney WT; Bowman RE; Bushnell P
    Nat New Biol; 1972 Dec; 240(104):286-7. PubMed ID: 4633263
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of prenylamine on locomotor activity and brain monoamine levels in mice.
    Ahtee L; Kärki N
    Acta Pharmacol Toxicol (Copenh); 1968; 26(1):55-63. PubMed ID: 5694266
    [No Abstract]   [Full Text] [Related]  

  • 38. Central cardiovascular effects of phentolamine in chloralose-anesthetized cats.
    Vollmer RR; Buckley JP
    Eur J Pharmacol; 1977 May; 43(1):17-25. PubMed ID: 862661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Locomotor activity and regional brain noradrenaline levels in rats treated with prenylamine.
    Broitman ST; Donoso AO
    Experientia; 1971; 27(11):1308-9. PubMed ID: 5134289
    [No Abstract]   [Full Text] [Related]  

  • 40. Brain levels of serotonin (5-HT) and norepinephrine (NE) during mescaline-induced behavior in mice.
    Shah NS
    Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):201-4. PubMed ID: 4686103
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.